Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Immunomodulatory Role of Vitamin D in Respiratory Diseases

Author(s): Giulio Pulvirenti, Giuseppe Fabio Parisi*, Sara Manti, Amelia Licari, ">Michele Miraglia del Giudice, Carmelo Salpietro, Gian Luigi Marseglia and Salvatore Leonardi

Volume 15, Issue 3, 2019

Page: [238 - 245] Pages: 8

DOI: 10.2174/1573398X15666191114144230

conference banner
Abstract

The growing interest in the new role of vitamin D, particularly as an immunomodulatory factor, has spurred basic research and the development of clinical trials to better understand the influence of supplementation on various diseases. Vitamin D is an important nutrient factor in human health due to its role in calcium metabolism regulation, cellular growth, differentiation and its fundamental discovered activity in immune functions. It has influenced different diseases, particularly inflammatory and autoimmune diseases, through immune response regulation, modulating innate and adaptive immunity.

The aim of this review was to explore the role of vitamin D in the main respiratory diseases in children such as asthma, chronic rhinosinusitis, cystic fibrosis and recurrent respiratory infections.

Keywords: Asthma, cystic fibrosis, recurrent respiratory infections, respiratory disease, Vitamin D, immunomodulatory.

« Previous
Graphical Abstract

[1]
Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2013; 45(2): 256-66.
[http://dx.doi.org/10.1007/s12016-012-8342-y] [PMID: 23238772]
[2]
Sassi F, Tamone C, D’Amelio P, Vitamin D. Nutrient, Hormone, and Immunomodulator. Nutrients 2018; 10(11) E1656
[http://dx.doi.org/10.3390/nu10111656] [PMID: 30400332]
[3]
Zhang Z, Chen F, Li J, et al. 1,25(OH)2D3 suppresses proinflammatory responses by inhibiting Th1 cell differentiation and cytokine production through the JAK/STAT pathway. Am J Transl Res 2018; 10(8): 2737-46.
[PMID: 30210711]
[4]
Komisarenko YI, Bobryk MI, Vitamin D. Deficiency and Immune Disorders in Combined Endocrine Pathology. Front Endocrinol (Lausanne) 2018; 9: 600.
[http://dx.doi.org/10.3389/fendo.2018.00600] [PMID: 30356853]
[5]
Ahlawat Rajni, Weinstein Toba, Pettei Michael J. Vitamin D in pediatric gastrointestinal disease. Wolters Kluwer Health. Inc 2017; 29(1): 122-7.
[http://dx.doi.org/10.1097/MOP.0000000000000451]
[6]
Finch SL, Rosenberg AM, Vatanparast H. Vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2018; 16(1): 34.
[http://dx.doi.org/10.1186/s12969-018-0250-0] [PMID: 29769136]
[7]
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30.
[http://dx.doi.org/10.1210/jc.2011-0385] [PMID: 21646368]
[8]
Dimeloe S, Rice LV, Chen H, et al. Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10. J Steroid Biochem Mol Biol 2019; 189: 1-9.
[http://dx.doi.org/10.1016/j.jsbmb.2019.01.014] [PMID: 30690074]
[9]
Vanherwegen AS, Eelen G, Ferreira GB, et al. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism. J Steroid Biochem Mol Biol 2019; 187: 134-45.
[http://dx.doi.org/10.1016/j.jsbmb.2018.11.011] [PMID: 30481575]
[10]
Blau JE, Collins MT. The PTH-Vitamin D-FGF23 axis. Rev Endocr Metab Disord 2015; 16(2): 165-74.
[http://dx.doi.org/10.1007/s11154-015-9318-z] [PMID: 26296372]
[11]
Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 2011; 39(21): 9181-93.
[http://dx.doi.org/10.1093/nar/gkr654] [PMID: 21846776]
[12]
Bettoun DJ, Buck DW II, Lu J, Khalifa B, Chin WW, Nagpal S. A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J Biol Chem 2002; 277(28): 24847-50.
[http://dx.doi.org/10.1074/jbc.C200187200] [PMID: 12036952]
[13]
Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224(4656): 1438-40.
[http://dx.doi.org/10.1126/science.6427926] [PMID: 6427926]
[14]
Bscheider M, Butcher EC. Vitamin D immunoregulation through dendritic cells. Immunology 2016; 148(3): 227-36.
[http://dx.doi.org/10.1111/imm.12610] [PMID: 27040466]
[15]
Booth DR, Ding N, Parnell GP, et al. Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases. Genes Immun 2016; 17(4): 213-9.
[http://dx.doi.org/10.1038/gene.2016.12] [PMID: 26986782]
[16]
Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013; 78(2): 127-36.
[http://dx.doi.org/10.1016/j.steroids.2012.10.019] [PMID: 23178257]
[17]
Leonardi S, Filippelli M, Lanzafame A, et al. Serum ykl-40 in children with asthma. J Biol Regul Homeost Agents 2015 Apr-Jun; 29(2)(Suppl. 1): 114-9.
[18]
Caccamo D, Ferlazzo N, Currò M, Ricca S, Ientile R. Transglutaminase 2 Up-Regulation Is Associated with Inflammatory Response in PBMC from Healthy Subjects with Hypovitaminosis D. Med Sci (Basel) 2018; 6(4) E103
[http://dx.doi.org/10.3390/medsci6040103] [PMID: 30453584]
[19]
Mukherjee S, Lindell DM, Berlin AA, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011; 179(1): 248-58.
[http://dx.doi.org/10.1016/j.ajpath.2011.03.003] [PMID: 21703407]
[20]
Jiao J, Castro M. Vitamin D and asthma: current perspectives. Curr Opin Allergy Clin Immunol 2015; 15(4): 375-82.
[http://dx.doi.org/10.1097/ACI.0000000000000187] [PMID: 26106827]
[21]
Brehm JM, Acosta-Pérez E, Klei L, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med 2012; 186(2): 140-6.
[http://dx.doi.org/10.1164/rccm.201203-0431OC] [PMID: 22652028]
[22]
Kaaviyaa AT, Krishna V, Arunprasath TS, Ramanan PV, Vitamin D. Deficiency as a factor influencing asthma control in children. Indian Pediatr 2018; 55(11): 969-71.
[http://dx.doi.org/10.1007/s13312-018-1420-3] [PMID: 30587645]
[23]
Pfeffer PE, Mann EH, Hornsby E, et al. Vitamin D influences asthmatic pathology through its action on diverse immunological pathways. Ann Am Thorac Soc 2014; 11(Suppl. 5): S314-21.
[http://dx.doi.org/10.1513/AnnalsATS.201405-204AW] [PMID: 25525739]
[24]
Peçanha MB, Freitas RB, Moreira TR, Silva LS, Oliveira LL, Cardoso SA. Prevalence of vitamin D deficiency and its relationship with factors associated with recurrent wheezing. J Bras Pneumol 2019; 45(1) e20170431
[http://dx.doi.org/10.1590/1806-3713/e20170431] [PMID: 30758429]
[25]
Riverin BD, Maguire JL, Li P, Vitamin D. Supplementation for Childhood Asthma: A Systematic Review and Meta-Analysis. PLoS One 2015; 10(8) e0136841
[http://dx.doi.org/10.1371/journal.pone.0136841] [PMID: 26322509]
[26]
Kerley CP, Hutchinson K, Cormican L, et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Pediatr Allergy Immunol 2016; 27(4): 404-12.
[http://dx.doi.org/10.1111/pai.12547] [PMID: 26845753]
[27]
Wandalsen GF, Solé D. Vitamin D and Asthma: a relationship to be clarified. Rev Paul Pediatr 2018; 36(3): 250-1.
[http://dx.doi.org/10.1590/1984-0462/;2018;36;3;00020] [PMID: 30365806]
[28]
Jensen ME, Mailhot G, Alos N, et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): A pilot randomised controlled trial. Trials 2016; 17(1): 353.
[http://dx.doi.org/10.1186/s13063-016-1483-1] [PMID: 27456232]
[29]
Martineau AR, Cates CJ, Urashima M, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev 2016; 9 CD011511
[http://dx.doi.org/10.1002/14651858.CD011511.pub2] [PMID: 27595415]
[30]
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91(5): 1255-60.
[http://dx.doi.org/10.3945/ajcn.2009.29094] [PMID: 20219962]
[31]
Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr 2014; 81(7): 650-4.
[http://dx.doi.org/10.1007/s12098-013-1268-4] [PMID: 24193954]
[32]
Tachimoto H, Mezawa H, Segawa T, Akiyama N, Ida H, Urashima M. Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: A randomized, double-blind, placebo-controlled trial. Allergy 2016; 71(7): 1001-9.
[http://dx.doi.org/10.1111/all.12856] [PMID: 26841365]
[33]
Pojsupap S, Iliriani K, Sampaio TZ, et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J Asthma 2015; 52(4): 382-90.
[http://dx.doi.org/10.3109/02770903.2014.980509] [PMID: 25365192]
[34]
Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med 2017; 5(11): 881-90.
[http://dx.doi.org/10.1016/S2213-2600(17)30306-5] [PMID: 28986128]
[35]
Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015; 7(6): 4240-70.
[http://dx.doi.org/10.3390/nu7064240] [PMID: 26035247]
[36]
Chen Y, Xu T. Association of vitamin D receptor expression with inflammatory changes and prognosis of asthma. Exp Ther Med 2018; 16(6): 5096-102.
[http://dx.doi.org/10.3892/etm.2018.6867] [PMID: 30542464]
[37]
Huang Y, Wang L, Jia XX, Lin XX, Zhang WX. Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway. Int Immunopharmacol 2019; 68: 88-94.
[http://dx.doi.org/10.1016/j.intimp.2018.12.061] [PMID: 30616171]
[38]
Bose S, Diette GB, Woo H, et al. Vitamin D status modifies the response to indoor particulate matter in obese urban children with asthma. J Allergy Clin Immunol Pract 2019; 7(6): 1815-1822.e2.
[http://dx.doi.org/10.1016/j.jaip.2019.01.051] [PMID: 30763731]
[39]
Santos HLBS, Silva SSE, Paula E, et al. Vitamin D receptor gene mutations and vitamin D serum levels in asthmatic children. Rev Paul Pediatr 2018; 36(3): 269-74.
[http://dx.doi.org/10.1590/1984-0462/;2018;36;3;00016] [PMID: 30066819]
[40]
Cho SW, Kim JH, Choi JH, Lim DH. Preventive and therapeutic effects of vitamin D in a mouse model of allergic asthma. Asian Pac J Allergy Immunol 2019; 37(3): 130-7.
[PMID: 30447649]
[41]
Ramireddy S, Raghuraman P, Khandelwal P, Abraham J, Sudandiradoss C. A molecular simulation analysis of vitamin D targets interleukin 13 (IL13) as an alternative to mometasone in asthma. 3 Biotech 2018; 8(8): 373.
[http://dx.doi.org/10.1007/s13205-018-1394-9]
[42]
Qiu YY, Zhou XY, Qian XF, Wu YX, Qin C, Bian T. 1,25-dihydroxyvitamin D3 reduces mouse airway inflammation of neutrophilic asthma by transcriptional modulation of interleukin-17A. Am J Transl Res 2017; 9(12): 5411-21.
[PMID: 29312493]
[43]
Shahangian A, Schlosser RJ. Role of Vitamin D in Pathogenesis of Chronic Sinusitis with Nasal Polyposis. Adv Otorhinolaryngol 2016; 79: 86-90.
[http://dx.doi.org/10.1159/000445136] [PMID: 27466850]
[44]
Schlosser RJ, Soler ZM, Schmedes GW, Storck K, Mulligan JK. Impact of vitamin D deficiency upon clinical presentation in nasal polyposis. Int Forum Allergy Rhinol 2014; 4(3): 196-9.
[http://dx.doi.org/10.1002/alr.21274] [PMID: 24415576]
[45]
Pinto JM, Schneider J, Perez R, DeTineo M, Baroody FM, Naclerio RM. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol 2008; 122(2): 415-7.
[http://dx.doi.org/10.1016/j.jaci.2008.05.038] [PMID: 18585770]
[46]
Faghih Habibi A, Gerami H, Banan R, et al. Serum 25-hydroxy vitamin D in chronic rhinosinusitis with and without nasal polyposis: A case-control study. Iran J Otorhinolaryngol 2019; 31(102): 19-24.
[PMID: 30783595]
[47]
Mulligan JK, Pasquini WN, Carroll WW, et al. Dietary vitamin D3 deficiency exacerbates sinonasal inflammation and alters local 25(OH)D3 metabolism. PLoS One 2017; 12(10) e0186374
[http://dx.doi.org/10.1371/journal.pone.0186374] [PMID: 29045457]
[48]
Konstantinidis I, Fotoulaki M, Iakovou I, et al. Vitamin D3 deficiency and its association with nasal polyposis in patients with cystic fibrosis and patients with chronic rhinosinusitis. Am J Rhinol Allergy 2017; 31(6): 395-400.
[http://dx.doi.org/10.2500/ajra.2017.31.4484] [PMID: 29122084]
[49]
Taha MS, Abdel Hamid T, Omran A, Lotfi N. Evaluation of vitamin D levels in allergic fungal sinusitis, chronic rhinosinusitis, and chronic rhinosinusitis with polyposis. Int Forum Allergy Rhinol 2016; 6(2): 185-90.
[50]
Schlosser RJ, Carroll WW, Soler ZM, Pasquini WN, Mulligan JK. Reduced sinonasal levels of 1α-hydroxylase are associated with worse quality of life in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 2016; 6(1): 58-65.
[http://dx.doi.org/10.1002/alr.21576] [PMID: 26575398]
[51]
Tomaszewska M, Sarnowska E, Rusetska N, et al. Role of Vitamin D and Its Receptors in the Pathophysiology of Chronic Rhinosinusitis. J Am Coll Nutr 2019; 38(2): 108-18.
[http://dx.doi.org/10.1080/07315724.2018.1503102] [PMID: 30388935]
[52]
Wang F, Yang Y, Chen H. Vitamin D deficiency are associated with subjective disease severity in Chinese patients with chronic rhinosinusitis with nasal polyps. Am J Otolaryngol 2019; 40(1): 36-9.
[http://dx.doi.org/10.1016/j.amjoto.2018.09.003] [PMID: 30322743]
[53]
Khalid AN, Ladha KS, Luong AU, Quraishi SA. Association of vitamin D status and acute rhinosinusitis: Results from the united states national health and nutrition examination survey 2001-2006. Medicine (Baltimore) 2015; 94(40) e1447
[http://dx.doi.org/10.1097/MD.0000000000001447] [PMID: 26447998]
[54]
Elbistanlı MS, Koçak HE, Güneş S, et al. Vit D deficiency is a possible risk factor in ARS. Eur Arch Otorhinolaryngol 2017; 274(9): 3391-5.
[http://dx.doi.org/10.1007/s00405-017-4635-3] [PMID: 28608241]
[55]
Stokes PJ, Rimmer J. The relationship between serum vitamin D and chronic rhinosinusitis: A systematic review. Am J Rhinol Allergy 2016; 30(1): 23-8.
[http://dx.doi.org/10.2500/ajra.2016.30.4267] [PMID: 26867526]
[56]
Mulligan JK, Bleier BS, O’Connell B, Mulligan RM, Wagner C, Schlosser RJ. Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol 2011; 164(3): 312-20.
[http://dx.doi.org/10.1111/j.1365-2249.2011.04325.x] [PMID: 21401575]
[57]
Christensen JM, Cheng J, Earls P, et al. Vitamin D pathway regulatory genes encoding 1α-hydroxylase and 24-hydroxylase are dysregulated in sinonasal tissue during chronic rhinosinusitis. Int Forum Allergy Rhinol 2017; 7(2): 169-76.
[http://dx.doi.org/10.1002/alr.21852] [PMID: 27618536]
[58]
Carroll WW, Schlosser RJ, O’Connell BP, Soler ZM, Mulligan JK. Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 2016; 6(6): 605-10.
[http://dx.doi.org/10.1002/alr.21704] [PMID: 26750566]
[59]
Frączek M, Kuśmierz D, Rostkowska-Nadolska B, Kutner A, Latocha MT. Antiproliferative and cytotoxic effect of selected vitamin d analogs on nasal polyps fibroblasts and other cells with higher proliferative potential. Acta Pol Pharm 2015; 72(5): 923-9.
[PMID: 26665399]
[60]
Wang LF, Tai CF, Chien CY, Chiang FY, Chen JY. Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis. Kaohsiung J Med Sci 2015; 31(5): 235-40.
[http://dx.doi.org/10.1016/j.kjms.2015.02.001] [PMID: 25910558]
[61]
Wang LF, Chien CY, Tai CF, Chiang FY, Chen JY. Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps. Kaohsiung J Med Sci 2015; 31(2): 63-9.
[http://dx.doi.org/10.1016/j.kjms.2014.11.011] [PMID: 25645983]
[62]
Sansoni ER, Sautter NB, Mace JC, et al. Vitamin D3 as a novel regulator of basic fibroblast growth factor in chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol 2015; 5(3): 191-6.
[http://dx.doi.org/10.1002/alr.21474] [PMID: 25561293]
[63]
Fraczek M, Rostkowska-Nadolska B, Kusmierz D, et al. Vitamin D analogs decrease in vitro secretion of RANTES and enhance the effect of budesonide. Adv Med Sci 2012; 57(2): 290-5.
[http://dx.doi.org/10.2478/v10039-012-0043-5] [PMID: 23183768]
[64]
Mulligan JK, White DR, Wang EW, et al. Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 2012; 147(4): 773-81.
[http://dx.doi.org/10.1177/0194599812448852] [PMID: 22627120]
[65]
Yawn J, Lawrence LA, Carroll WW, Mulligan JK. Vitamin D for the treatment of respiratory diseases: is it the end or just the beginning? J Steroid Biochem Mol Biol 2015; 148: 326-37.
[http://dx.doi.org/10.1016/j.jsbmb.2015.01.017] [PMID: 25625665]
[66]
Leonardi S, Parisi GF, Capizzi A, et al. YKL-40 as marker of severe lung disease in cystic fibrosis patients. J Cyst Fibros 2016; 15(5): 583-6.
[http://dx.doi.org/10.1016/j.jcf.2015.12.020] [PMID: 26778616]
[67]
Grzelak T, Mikołajczyk K. Pleiotropic effect of vitamin D in cystic fibrosis. Adv Respir Med 2018.
[PMID: 30110122]
[68]
Chesdachai S, Tangpricha V. Treatment of vitamin D deficiency in cystic fibrosis. J Steroid Biochem Mol Biol 2016; 164: 36-9.
[http://dx.doi.org/10.1016/j.jsbmb.2015.09.013] [PMID: 26365559]
[69]
Sexauer WP, Hadeh A, Ohman-Strickland PA, et al. Vitamin D deficiency is associated with pulmonary dysfunction in cystic fibrosis. J Cyst Fibros 2015; 14(4): 497-506.
[http://dx.doi.org/10.1016/j.jcf.2014.12.006] [PMID: 25577127]
[70]
Bravo MP, Balboa P, Torrejón C, et al. Bone mineral density, lung function, vitamin D and body composition in children and adolescents with cystic fibrosis: a multicenter study. Nutr Hosp 2018; 35(4): 789-95.
[http://dx.doi.org/10.20960/nh.1609] [PMID: 30070865]
[71]
Pincikova T, Paquin-Proulx D, Sandberg JK, Flodström-Tullberg M, Hjelte L. Vitamin D treatment modulates immune activation in cystic fibrosis. Clin Exp Immunol 2017; 189(3): 359-71.
[http://dx.doi.org/10.1111/cei.12984] [PMID: 28470739]
[72]
Oliveira MS, Matsunaga NY, Rodrigues MLE, et al. Lung disease and vitamin D levels in cystic fibrosis infants and preschoolers. Pediatr Pulmonol 2019; 54(5): 536-74.
[http://dx.doi.org/10.1002/ppul.24260]
[73]
Simoneau T, Sawicki GS, Milliren CE, Feldman HA, Gordon CM. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients. J Cyst Fibros 2016; 15(2): 234-41.
[http://dx.doi.org/10.1016/j.jcf.2015.07.004] [PMID: 26211605]
[74]
Timmers NKLM, Stellato RK, van der Ent CK, Houwen RHJ, Woestenenk JW. Vitamin D intake, serum 25-hydroxy vitamin D and pulmonary function in paediatric patients with cystic fibrosis: a longitudinal approach. Br J Nutr 2019; 121(2): 195-201.
[http://dx.doi.org/10.1017/S0007114518003021] [PMID: 30442206]
[75]
Thursfield RM, Naderi K, Leaver N, et al. Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency. J Cyst Fibros 2018; 17(5): 657-65.
[http://dx.doi.org/10.1016/j.jcf.2018.02.011] [PMID: 29631774]
[76]
Tangpricha V, Smith EM, Binongo J, et al. The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis. Contemp Clin Trials Commun 2017; 6: 39-45.
[http://dx.doi.org/10.1016/j.conctc.2017.02.010] [PMID: 28508087]
[77]
Olszowiec-Chlebna M, Koniarek-Maniecka A, Brzozowska A, Błauż A, Rychlik B, Stelmach I. Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study. Ital J Pediatr 2019; 45(1): 41.
[http://dx.doi.org/10.1186/s13052-019-0634-x] [PMID: 30922377]
[78]
Pincikova T, Paquin-Proulx D, Sandberg JK, Flodström-Tullberg M, Hjelte L. Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial. Eur J Clin Nutr 2017; 71(2): 203-5.
[http://dx.doi.org/10.1038/ejcn.2016.259] [PMID: 27966575]
[79]
Bartley J, Garrett J, Camargo CA Jr, et al. Vitamin D3 supplementation in adults with bronchiectasis: A pilot study. Chron Respir Dis 2018; 15(4): 384-92.
[http://dx.doi.org/10.1177/1479972318761646] [PMID: 29490469]
[80]
Moustaki M, Loukou I, Priftis KN, Douros K. Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis. World J Clin Pediatr 2017; 6(3): 132-42.
[http://dx.doi.org/10.5409/wjcp.v6.i3.132] [PMID: 28828295]
[81]
Abu-Fraiha Y, Elyashar-Earon H, Shoseyov D, et al. Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis. J Pediatr Gastroenterol Nutr 2019; 68(1): 110-5.
[http://dx.doi.org/10.1097/MPG.0000000000002126] [PMID: 30095576]
[82]
DiFranco KM, Mulligan JK, Sumal AS, Diamond G. Induction of CFTR gene expression by 1,25(OH)2 vitamin D3, 25OH vitamin D3, and vitamin D3 in cultured human airway epithelial cells and in mouse airways. J Steroid Biochem Mol Biol 2017; 173: 323-32.
[http://dx.doi.org/10.1016/j.jsbmb.2017.01.013] [PMID: 28130182]
[83]
Kanhere M, Chassaing B, Gewirtz AT, Tangpricha V. Role of vitamin D on gut microbiota in cystic fibrosis. J Steroid Biochem Mol Biol 2018; 175: 82-7.
[http://dx.doi.org/10.1016/j.jsbmb.2016.11.001] [PMID: 27818276]
[84]
Ferri S, Crimi C, Heffler E, Campisi R, Noto A, Crimi N. Vitamin D and disease severity in bronchiectasis. Respir Med 2019; 148: 1-5.
[http://dx.doi.org/10.1016/j.rmed.2019.01.009] [PMID: 30827468]
[85]
Kanhere M, He J, Chassaing B, et al. Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab 2018; 103(2): 564-74.
[http://dx.doi.org/10.1210/jc.2017-01983] [PMID: 29161417]
[86]
Zhang X, Ding F, Li H, et al. Low Serum Levels of Vitamins A, D, and E Are Associated with Recurrent Respiratory Tract Infections in Children Living in Northern China: A Case Control Study. PLoS One 2016; 11(12) e0167689
[http://dx.doi.org/10.1371/journal.pone.0167689] [PMID: 27936124]
[87]
Dąbrowska-Leonik N, Bernatowska E, Pac M, et al. Vitamin D deficiency in children with recurrent respiratory infections, with or without immunoglobulin deficiency. Adv Med Sci 2018; 63(1): 173-8.
[http://dx.doi.org/10.1016/j.advms.2017.08.001] [PMID: 29128760]
[88]
Özdemir B, Köksal BT, Karakaş NM, Tekindal MA, Özbek ÖY. Serum Vitamin D Levels in Children with Recurrent Respiratory Infections and Chronic Cough. Indian J Pediatr 2016; 83(8): 777-82.
[http://dx.doi.org/10.1007/s12098-015-2010-1] [PMID: 26821547]
[89]
Stenberg Hammar K, Hedlin G, Konradsen JR, et al. Subnormal levels of vitamin D are associated with acute wheeze in young children. Acta Paediatr 2014; 103(8): 856-61.
[http://dx.doi.org/10.1111/apa.12666] [PMID: 24766450]
[90]
Hibbs AM, Ross K, Kerns LA, et al. Effect of Vitamin D Supplementation on Recurrent Wheezing in Black Infants Who Were Born Preterm: The D-Wheeze Randomized Clinical Trial. JAMA 2018; 319(20): 2086-94.
[http://dx.doi.org/10.1001/jama.2018.5729] [PMID: 29800180]
[91]
Arihiro S, Nakashima A, Matsuoka M, et al. Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2019; 25(6): 1088-95.
[http://dx.doi.org/10.1093/ibd/izy346] [PMID: 30601999]
[92]
Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 356: i6583.
[http://dx.doi.org/10.1136/bmj.i6583] [PMID: 28202713]
[93]
Stagi S, Bertini F, Rigante D, Falcini F. Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Int J Pediatr Otorhinolaryngol 2014; 78(6): 964-8.
[http://dx.doi.org/10.1016/j.ijporl.2014.03.026] [PMID: 24746456]
[94]
Cayir A, Turan MI, Ozkan O, et al. Serum vitamin D levels in children with recurrent otitis media. Eur Arch Otorhinolaryngol 2014; 271(4): 689-93.
[http://dx.doi.org/10.1007/s00405-013-2455-7] [PMID: 23543299]

Rights & Permissions Print Cite
Article Metrics
32
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy